Diana V. Do, MD, is Vice Chair of Clinical Affairs and Professor of Ophthalmology at the Byers Eye Institute, Stanford University School of Medicine. She is a leading surgeon-scientist who has over 15 years of experience in clinical trials and retinal research. She has an active clinical practice and specializes in the surgical and medical treatment of retinal disorders. She has been the principal investigator and co-investigator on more than 35 clinical trials investigating novel treatments for retinal diseases such as neovascular age-related macular degeneration, diabetic macular edema, diabetic retinopathy, and retinal vein occlusion. She has authored over 125 publications in the medical literature and has contributed to over 25 book chapters.
Financial disclosure: Dr. Do has/had an affiliation (financial or otherwise) with a commercial organization:
- Apellis
- Iveric
- Kodiak Sciences
- Kriya
- REGENXBIO
- Regeneron
Sessions in which Diana V. Do, MD participates
Friday 16 June, 2023
*Breakfast to be served from 6:00am* Learning Objectives:At the end of this session, participants will be able to:Identify innovative canadian retina research proposalsand their intended benefitDescribe how using emerging therapies can improvethe care of patientsCanMEDS Roles: Medical Expert, Scholar
Learning Objectives: At the end of this session, participants will be able to: Understand the concept of retinal displacement in retinal detachment repair and the various factors affecting itAssess the use of multi-modal imaging technologies to optimize surgical resultsIntegrate peripheral retinal imaging in the assessment of retinal pathologiesCanMEDS Roles:
Learning Objectives: At the end of this session, participants will be able to: Assess new therapeutic modalities for dry age-related macular degenerationAssess current therapies for wet age-related macular degenerationAssess complications of anti-VGF treatments and preventative measuresCanMEDS Roles: Medical Expert, Scholar
Learning Objectives: At the end of this session, participants will be able to: Assess the use of multi-modal imaging in assessing retinal pathologyAssess new technologies in imaging of the retinaIntegrate new management strategies for diabetic retinopathyCanMEDS Roles: Medical Expert, Scholar
Saturday 17 June, 2023
*Breakfast to be served from 6:00am* Learning Objectives: At the end of this session, participants will be able to: Outline the role of the Tie-2/ang pathway in DR and nAMDand how it may impact patient outcomesIdentify the most important biomarkerson structural OCT that can help predict treatmentresponse in DME and nAMDDiscuss r...
Learning Objectives:At the end of this session, participants will be able to:Elucidate the cause and mechanism of DVD.Identity indications of Light adjustable lensXX